Bain utilizza i cookie per migliorare la funzionalità e le prestazioni di questo sito. Ulteriori informazioni in merito si trovano nella nostra Informativa sulla Privacy. Continuando a navigare su questo sito, acconsenti all'uso dei cookie.

Medtech Dive

Medtechs eye key role of ASCs in return of elective care

Medtechs eye key role of ASCs in return of elective care

The flight of joint replacements and other lucrative procedures from acute care hospitals to ambulatory surgery centers was happening before the COVID-19 pandemic, but the crisis may prove to accelerate the trend

  • maggio 26, 2020
  • Tempo di lettura min.

Medtech Dive

Medtechs eye key role of ASCs in return of elective care

The flight of joint replacements and other lucrative procedures from acute care hospitals to ambulatory surgery centers was happening before the COVID-19 pandemic, but the crisis may prove to accelerate the trend.

“That shift was underway, but not very quickly: things never are in healthcare,” said Tim van Biesen, head of Bain & Company’s global healthcare practice.

Some 5,700 ASCs in the U.S. carried out 23 million procedures in 2018, according to data cited by Bain last fall. The year prior, ASCs reportedly carried out more than half of all outpatient surgeries, versus having 32% share 15 years ago.

Vedi di più su Medtech Dive